Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g/L: a systematic review
Cerebrospinal fluid total protein (CSF-TP) is measured in the diagnosis of a range of immune or infectious disorders of the nervous system. Most laboratories and the medical literature use an antiquated, age-independent upper limit of 0.45 g/L. Therefore, we performed a systematic review of reference studies in the medical literature, with the primary objective of determining the CSF total protein upper reference limit (URL). Secondary objectives were to assess the effects of age, gender, laboratory methods, and methodological quality.
A pre-planned and peer-reviewed electronic search strategy was used to search Ovid Medline and EMBASE for 1960–2017. All records underwent title/abstract review, and potentially relevant records underwent independent full-text review by two researchers. The remaining studies underwent quality assessment using a modification of the QUADAS2 revised tool. CSF-TP upper reference limits extracted from these studies were used to compute weighted means.
Twenty-two articles were retained for qualitative analysis and 20 for quantitative analysis. The weighted average of CSF-TP URL was 0.55 g/L, in studies with high methodological quality. Studies that examined the effect of age reported consistent correlations with advancing age, and CSF-TP URL values incrementally exceeded 0.60 g/L after age 50. There were no meaningful differences according to gender, laboratory method, or quality assessment score.
There is concordance in available literature to recommend increasing CSF total protein upper reference limits, and to consider implementing age-adjusted values above 0.60 g/L starting at age 50. This information merits worldwide dissemination, to reduce the risk of over-diagnosis.
KeywordsCerebrospinal fluid CSF CSF total protein Upper reference limits Systematic review
AB, PB: conception of the work, data acquisition, data interpretation, drafting of manuscript. DM, WC: data analysis, revision of manuscript for critically important intellectual content. JB, HH, FD, CM: contributions to study design, data interpretation, and revisions for critically important intellectual content.
Compliance with ethical standards
Conflicts of interest
No relevant conflicts or competing interests.
- 1.Merritt Houston, H F-SF (1937) The cerebrospinal fluid. W.B. Saunders, PhiladelphiaGoogle Scholar
- 2.Daroff RB, Bradley WG, Jankovic J, Mazziotta JC, Pomeroy SL, Elsevier (2016) Bradley’s neurology in clinical practice, vol 2. Elsevier, London [etc.]Google Scholar
- 3.Goldman L, Schafer AI (2016) Goldman-cecil medicine, 25th edn. Elsevier/Saunders, Philadelphia, PA, USAGoogle Scholar
- 6.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100CrossRefGoogle Scholar
- 9.R Core Team (2017) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/
- 10.Lott JA, Warren P (1989) Estimation of reference intervals for total protein in cerebrospinal fluid. Clin Chem 35:1766–1770Google Scholar
- 13.Merril CR, Harrington MG (1984) ‘Ultrasensitive’ silver stains: their use exemplified in the study of normal human cerebrospinal fluid proteins separated by two-dimensional electrophoresis. Clin Chem 30:1938–1942Google Scholar
- 17.Bernhardt W, Weisner B, Rehpenning W (1978) Laboratory findings in cerebrospinal fluid in relation to age: trivariate evaluation of albumin and immunoglobulin G concentrations. J Clin Chem Clin Biochem 16:435–439 (author’s transl) Google Scholar
- 19.Thomsen J, Bech P, Nielsen OS (1978) CSF total protein: normal values. A re-appraisal and discussion of its value in diagnosis of acoustic neuromas. Acta Oto-Laryngol 86:359–365Google Scholar
- 23.Mertin J, Wisser H, Doerr P (1971) Studies on the normal concentration range of total protein and the total protein fractions of the cerebrospinal fluid by electrophoresis on cellulose acetate. Zeitschrift fur klinische Chemie klinische Biochemie 9:337–340 (author’s transl) Google Scholar
- 24.Igou PC (1967) Normal values for cellulose acetate electrophoresis of spinal fluid proteins. Amer J Med Technol 33:501–504Google Scholar
- 26.Arnold F (1966) Cerebrosplnal liquid examinations in healthy individuals and in patients with multiple sclerosis. Schweizerische Medizinische Wochenschrift 96:1098–1103Google Scholar
- 28.Rieder HP, Wuthrich R (1962) The cu-folin method for determining the total proteinsin the csf. KljnWschr 40:241–255Google Scholar
- 30.Breebaart K, Becker H, Jongebloed FA (1978) Investigation of reference values of components of cerebrospinal fluid. J Clin Chem Clin Biochem 16:561–565Google Scholar
- 31.Teunissen C, Menge T, Altintas A, Alvarez-Cermeno JC, Bertolotto A, Berven FS, Brundin L, Comabella M, Degn M, Deisenhammer F, Fazekas F, Franciotta D, Frederiksen JL, Galimberti D, Gnanapavan S, Hegen H, Hemmer B, Hintzen R, Hughes S, Iacobaeus E, Kroksveen AC, Kuhle J, Richert J, Tumani H, Villar LM, Drulovic J, Dujmovic I, Khalil M, Bartos A (2013) Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 19:1802–1809CrossRefGoogle Scholar
- 33.Kleine TO, Weber L, Zofel P (1988) Changes with age in leucocyte counts, protein and IgG content of lumbar cerebrospinal fluid (CSF) of patients with inflammatory, ischemic, and hemorrhagic diseases or tumors of the central nervous system (CNS). Zeitschrift fur Gerontologie 21:102–105Google Scholar
- 39.Lott JA, Mitchell LC, Moeschberger ML, Sutherland DE (1992) Estimation of reference ranges: how many subjects are needed? Clin Chem 38:648–650Google Scholar